Fabrice Cognasse: The EFS Is First and Foremost Part of a Medical Discipline – Transfusion
Fabrice Cognasse, Director of Research – Scientific Director at The EFS in Auvergne-Rhône-Alpes and INSERM, shared a post on LinkedIn:
”Two very enriching sessions today with the teams of the Bourg-en-Bresse site around the Scientific Department of the EFS AuRA / Inserm!
Fascinating exchanges, relevant questions and a strong conviction: the scientific approach is everywhere at the EFS.
It guides both our medico-technical activities and our support functions, in the service of quality, innovation and patients.
The EFS is first and foremost part of a medical discipline: transfusion.
A scientific heritage that dates back in particular to Jean-Baptiste Denis, a pioneer of the first transfusion experiments in the seventeenth century and a founding figure in the history of blood transfusion.
This scientific curiosity, this desire to understand, improve and innovate are fully shared by the teams – and it’s a real collective strength!
Thank you all for your warm welcome and the richness of the exchanges!”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 20:01Anand Gupta: Timing of DOAC Initiation in Newly Diagnosed Atrial Fibrillation
-
Sep 25, 2026, 19:56Steven Fein: A History of Blood Clots Doesn’t Mean a Healthy Pregnancy Is Out of Reach
-
Sep 25, 2026, 19:54Pedro Perez: “Provoked” VTE May Not Always Mean the Risk Disappears When the Provoking Event Does
-
Sep 25, 2026, 19:53Kemal Karaagac: Calcitriol May Reduce Thrombotic Risk in MASLD
-
Sep 25, 2026, 19:52The SINGLE-AF Trial Anticoagulation for Intermediate Stroke Risk – NEJM
-
Sep 25, 2026, 19:49Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
-
Sep 25, 2026, 19:47Bryan Cotton: DOACs Versus Nothing When Stroke Risk Is Not Zero
-
Sep 25, 2026, 19:45Selin Yaman Seval: ITP Is More Than a Low Platelet Count
-
Sep 25, 2026, 19:44Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count